GENETIC RISK FACTORS OF ANTHRACYCLINE CARDIOTOXICITY - RELEVANT POLYMORPHISMS IDENTIFIED IN ENZYMES AND TRANSPORTERS OF ANTHRACYCLINE PHARMACOKINETICS

被引：0
|
作者：
Kutszegi, Nora Zsofia [1 ]
Semsei, Agnes F. [1 ]
Lautner-Csorba, Orsolya [1 ]
Hegyi, Marta [2 ]
Szabolcs, Judit [2 ]
Benyo, Gabor [3 ]
Szalai, Csaba [1 ,4 ]
Kovacs, Gabor T. [2 ]
Erdelyi, Daniel Janos [2 ]
机构：
[1] Semmelweis Univ, Dept Genet Cell & Immunobiol, H-1085 Budapest, Hungary
[2] Semmelweis Univ, Dept Paediat 2, H-1085 Budapest, Hungary
[3] Szent Laszlo Hosp, Budapest, Hungary
[4] Csertex Res Lab, Budapest, Hungary
来源：
PEDIATRIC BLOOD & CANCER | 2012年 / 59卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1101 / 1101
页数：1
相关论文
共 50 条
  • [21] Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk
    Gomez-Vecino, Aurora
    Corchado-Cobos, Roberto
    Blanco-Gomez, Adrian
    Garcia-Sancha, Natalia
    Castillo-Lluva, Sonia
    Martin-Garcia, Ana
    Mendiburu-Elicabe, Marina
    Prieto, Carlos
    Ruiz-Pinto, Sara
    Pita, Guillermo
    Velasco-Ruiz, Alejandro
    Patino-Alonso, Carmen
    Galindo-Villardon, Purificacion
    Vera-Pedrosa, Maria Linarejos
    Jalife, Jose
    Mao, Jian-Hua
    de Plasencia, Guillermo Macias
    Castellanos-Martin, Andres
    Saez-Freire, Maria del Mar
    Fraile-Martin, Susana
    Rodrigues-Teixeira, Telmo
    Garcia-Macias, Carmen
    Galvis-Jimenez, Julie Milena
    Garcia-Sanchez, Asuncion
    Isidoro-Garcia, Maria
    Fuentes, Manuel
    Garcia-Cenador, Maria Begona
    Garcia-Criado, Francisco Javier
    Garcia-Hernandez, Juan Luis
    Hernandez-Garcia, Maria Angeles
    Cruz-Hernandez, Juan Jesus
    Rodriguez-Sanchez, Cesar Augusto
    Garcia-Sancho, Alejandro Martin
    Perez-Lopez, Estefania
    Perez-Martinez, Antonio
    Gutierrez-Larraya, Federico
    Carton, Antonio J.
    Garcia-Saenz, Jose Angel
    Patino-Garcia, Ana
    Martin, Miguel
    Alonso-Gordoa, Teresa
    Vulsteke, Christof
    Croes, Lieselot
    Hatse, Sigrid
    Van Brussel, Thomas
    Lambrechts, Diether
    Wildiers, Hans
    Chang, Hang
    Holgado-Madruga, Marina
    Gonzalez-Neira, Anna
    CELLS, 2023, 12 (15)
  • [22] ANTHRACYCLINE CARDIOTOXICITY: THE PHARMACOKINETICS AND PHARMACODYNAMICS OF DEXRAZOXANE AND ITS OPEN RING METABOLITE
    Jirkovska-Vavrova, A.
    Jirkovsky, E.
    Stariat, J.
    Jansova, H.
    Roh, J.
    Lencova-Popelova, O.
    Kovarikova, P.
    Sterba, M.
    Simunek, T.
    HEART, 2014, 100
  • [23] Genetic Polymorphisms as Possible Factors Involved in the Onset of Anthracycline-Induced Cardiomyopathy
    Nodari, Savina
    Manerba, Alessandra
    Fragni, Martina
    Ambrosiani, Luca
    Triggiani, Marco
    Tucci, Alessandra
    Rossi, Giuseppe
    Simoncini, Edda L.
    Amoroso, Vito
    Berruti, Alfredo
    Ferrari, Vittorio
    Villa, Clara
    Calza, Stefano
    Memo, Maurizio
    Sigala, Sandra
    JOURNAL OF CARDIAC FAILURE, 2014, 20 (08) : S26 - S27
  • [24] Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children:: a systematic review
    Kremer, LCM
    van der Pal, HJH
    Offringa, M
    van Dalen, EC
    Voûte, PA
    ANNALS OF ONCOLOGY, 2002, 13 (06) : 819 - 829
  • [25] Risk factors for early anthracycline clinical cardiotoxicity in children: the pediatric oncology group experience
    Krischer, JP
    Cuthbertson, DD
    Epstein, S
    Goorin, AM
    Epstein, ML
    Lipshultz, SE
    PROGRESS IN PEDIATRIC CARDIOLOGY, 1997, 8 (02) : 83 - 90
  • [26] Anthracycline-induced cardiotoxicity: mechanisms of action, incidence, risk factors, prevention, and treatment
    Saleh, Yehia
    Abdelkarim, Ola
    Herzallah, Khader
    Abela, George S.
    HEART FAILURE REVIEWS, 2021, 26 (05) : 1159 - 1173
  • [27] Anthracycline-induced cardiotoxicity: mechanisms of action, incidence, risk factors, prevention, and treatment
    Yehia Saleh
    Ola Abdelkarim
    Khader Herzallah
    George S. Abela
    Heart Failure Reviews, 2021, 26 : 1159 - 1173
  • [28] FATAL ANTHRACYCLINE-INDUCED CARDIOTOXICITY IN A YOUNG PATIENT WITHOUT CARDIOVASCULAR RISK FACTORS
    Kim, Esther S.
    Vaysblat, Michael
    Bae, Suhwoo
    Khanijo, Sameer
    CHEST, 2024, 166 (04) : 512A - 513A
  • [29] Genomic Factors Associated With Anthracycline Cardiotoxicity in Pediatric Cancer Survivors
    Chaix, Marie
    Lafreniere-Roula, Myriam
    Akinrinade, Oyediran
    Yao, Roderick
    Miron, Anastasia
    Lam, Emily
    Christie, Anne
    Manickaraj, Kumar Ashok
    Marjerrison, Stacey
    Dillenburg, Rejane
    Bassal, Mylene
    Lougheed, Jane
    Zelcer, Shayna
    Rosenberg, Herschel
    Hodgson, David
    Sender, Leonard
    Greenberg, Mark
    Liu, Peter
    Kantor, Paul
    Manlhiot, Cedric
    Mertens, Luc
    Nathan, Paul
    Mital, Seema
    CIRCULATION, 2018, 138
  • [30] Machine Learning Identifies Clinical and Genetic Factors Associated With Anthracycline Cardiotoxicity in Pediatric Cancer Survivors
    Chaix, Marie-A
    Parmar, Neha
    Kinnear, Caroline
    Lafreniere-Roula, Myriam
    Akinrinade, Oyediran
    Yao, Roderick
    Miron, Anastasia
    Lam, Emily
    Meng, Guoliang
    Christie, Anne
    Manickaraj, Ashok Kumar
    Marjerrison, Stacey
    Dillenburg, Rejane
    Bassal, Mylene
    Lougheed, Jane
    Zelcer, Shayna
    Rosenberg, Herschel
    Hodgson, David
    Sender, Leonard
    Kantor, Paul
    Manlhiot, Cedric
    Ellis, James
    Mertens, Luc
    Nathan, Paul C.
    Mital, Seema
    JACC: CARDIOONCOLOGY, 2020, 2 (05): : 690 - 706
12345